Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fate Therapeutics (FATE)
NASDAQ:FATE
Holding FATE?
Track your performance easily
Fate Therapeutics (FATE) Ownership Overview
18.52% Insiders
16.12% Mutual Funds
2.41% Other Institutional Investors
13.10% ETFs
49.85% Public Companies and
Individual Investors
The ownership structure of Fate Therapeutics (FATE) stock is a mix of institutional, retail, and individual investors. Approximately 31.63% of the company’s stock is owned by Institutional Investors, 18.52% is owned by Insiders, and 49.85% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 10, 2024 | Cindy Tahl Gc & Secretary | xxxxxxxxxxxxx | $47519 |
| Jan 10, 2024 | Bahram Valamehr Chief R&d Officer | xxxxxxxxxxxxx | $49367 |
| Jan 10, 2024 | xxxxxxxxxxxxx | $30712 | |
| Jan 10, 2024 | Scott Wolchko President & Ceo,director | xxxxxxxxxxxxx | $62889 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $37933 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $566990 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $984000 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $1133486 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,180,388 | Insider | 11.57% | 31,896,539 | |
| 4,945,146 | Insider | 5.00% | 11,967,253 | |
| 5,283,634 | Institution | 4.64% | 12,786,394 | |
| 4,266,831 | Institution | 3.75% | 10,325,731 | |
| 4,073,499 | Institution | 3.58% | 9,857,868 | |
| 3,555,871 | Institution | 3.12% | 8,605,208 | |
| 3,329,001 | Institution | 2.92% | 8,056,182 | |
| 3,057,003 | Institution | 2.68% | 7,397,947 | |
| 2,997,772 | Institution | 2.63% | 7,254,608 | |
| 1,268,133 | Institution | 1.11% | 3,068,882 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,266,831 | Institution | 3.75% | 10,325,731 | |
| 3,329,001 | Institution | 2.92% | 8,056,182 | |
| 1,268,133 | Institution | 1.11% | 3,068,882 | |
| 1,145,259 | Institution | 1.01% | 2,771,527 | |
| 958,545 | Institution | 0.84% | 2,319,679 | |
| 942,066 | Institution | 0.83% | 2,279,800 | |
| 884,894 | Institution | 0.78% | 2,141,443 | |
| 834,739 | Institution | 0.73% | 2,020,068 | |
| 511,031 | Institution | 0.45% | 1,236,695 | |
| 510,751 | Institution | 0.45% | 1,236,017 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,049,285 | Institution | 2.68% | 10,672,498 | |
| 2,729,541 | Institution | 2.40% | 6,605,489 | |
| 2,417,920 | Institution | 2.12% | 6,165,696 | |
| 1,409,196 | Institution | 1.24% | 4,932,186 | |
| 957,041 | Institution | 0.84% | 2,316,039 | |
| 459,207 | Institution | 0.40% | 1,607,225 | |
| 566,084 | Institution | 0.50% | 1,443,514 | |
| 564,231 | Institution | 0.50% | 1,438,789 | |
| 435,547 | Institution | 0.38% | 1,110,645 | |
| 284,779 | Institution | 0.25% | 996,727 |
FAQ
Who Owns Fate Therapeutics (FATE)?
According to the latest TipRanks data, approximately 2.41% of the company's stock is held by institutional investors, 18.52% is held by insiders, and 49.85% is held by retail investors.
What percentage of Fate Therapeutics (FATE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.41% of Fate Therapeutics (FATE) stock is held by institutional investors.
What percentage of Fate Therapeutics (FATE) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.85% of Fate Therapeutics (FATE) stock is held by retail investors.
Who owns the most shares of Fate Therapeutics (FATE)?
Redmile Group, Llc owns the most shares of Fate Therapeutics (FATE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.